AI Revolution in Healthcare: Avant Technologies, Agenus, Clover Health, Zimmer Biomet, Monogram Technologies Lead the Way.
PorAinvest
martes, 22 de julio de 2025, 9:22 am ET2 min de lectura
AGEN--
Among the notable players in this space are Qure.ai, Deeptek, BrainSightAI, Jivi, and Insane AI. Qure.ai, founded in 2016, is a leader in AI-based image analysis tools for clinical labs, offering products like qXR and qER for disease diagnosis from CT scans, MRIs, and X-rays. Deeptek, established in 2017, provides AI-augmented diagnostic tools for radiology imaging, using cloud-powered GPU and deep neural networks to assist radiologists. BrainSightAI, founded in 2019, leverages AI and neuroscience for functional brain mapping, aiding in mental health and neurology investigations [1].
Investments in these startups are substantial. Qure.ai, for instance, has raised $123 million in total funding, with its latest Series D round securing $65 million in September 2024. Deeptek, on the other hand, has raised $10 million in Series A funding. Jivi, founded in 2023, has secured $2.99 million in seed funding. These investments reflect the growing interest and confidence in the potential of AI in healthcare [1].
The broader AI toolkit market is also experiencing robust growth, driven by increasing adoption across various sectors. According to a report by SNS Insider, the Artificial Intelligence Toolkit Market was valued at USD 22.2 billion in 2024 and is projected to reach USD 151.2 billion by 2032, expanding at a CAGR of 23.78% [3]. The market is fueled by the demand for automated workflows, data-driven insights, and intelligent decision-making, with open-source and software segments leading the market.
Moreover, the AI revolution is not confined to startups. Large tech companies like Google, Microsoft, IBM, and NVIDIA are also investing heavily in AI toolkits, indicating a broader trend towards AI integration in healthcare and other industries [3].
The regulatory landscape is gradually becoming more favorable for AI implementation in healthcare. Developers are overcoming barriers, moving closer to real-world implementation. Companies like Avant Technologies, Agenus, Clover Health, Zimmer Biomet, and Monogram Technologies are making progress in this area, further validating the potential of AI in transforming healthcare [1].
In conclusion, the AI revolution in healthcare is well underway, with significant investments and innovations from startups and established companies alike. The market is poised for substantial growth, driven by the potential to save lives and reduce costs. Investors and financial professionals should closely monitor this space for promising opportunities.
References:
[1] https://tracxn.com/d/explore/native-ai-in-healthcare-startups-in-india/__KIHHuaBJBYBU6ve5YGXs1pco5pOrgob_2DWmjE7RKsw/companies
[2] https://www.investing.com/news/company-news/reka-ai-raises-110-million-valuation-tops-1-billion-93CH-4145714
[3] https://www.globenewswire.com/news-release/2025/07/17/3117354/0/en/Artificial-Intelligence-Toolkit-Market-to-Reach-USD-151-2-Billion-by-2032-Driven-by-Enterprise-AI-Adoption-and-Open-Source-Growth-Research-by-SNS-Insider.html
CLOV--
GOOGL--
IBM--
MGRM--
The AI revolution in healthcare is underway, with potential to save lives and money. Healthcare startups are implementing AI to multiply patients and chase profits for investors. AI adoption is becoming norm among medical professionals, with more Americans using AI to diagnose health issues. Developers are overcoming regulatory barriers, moving closer to real-world implementation. Avant Technologies, Agenus, Clover Health, Zimmer Biomet, and Monogram Technologies are among the players making progress.
The AI revolution in healthcare is rapidly transforming the industry, with the potential to save lives and significantly reduce costs. India, in particular, is witnessing a surge in AI-driven healthcare startups, offering innovative solutions to diagnose and treat various health issues. According to Tracxn.com, there are 81 Native AI in Healthcare startups in India, with 40 of them funded, and 3 having secured Series A+ funding [1].Among the notable players in this space are Qure.ai, Deeptek, BrainSightAI, Jivi, and Insane AI. Qure.ai, founded in 2016, is a leader in AI-based image analysis tools for clinical labs, offering products like qXR and qER for disease diagnosis from CT scans, MRIs, and X-rays. Deeptek, established in 2017, provides AI-augmented diagnostic tools for radiology imaging, using cloud-powered GPU and deep neural networks to assist radiologists. BrainSightAI, founded in 2019, leverages AI and neuroscience for functional brain mapping, aiding in mental health and neurology investigations [1].
Investments in these startups are substantial. Qure.ai, for instance, has raised $123 million in total funding, with its latest Series D round securing $65 million in September 2024. Deeptek, on the other hand, has raised $10 million in Series A funding. Jivi, founded in 2023, has secured $2.99 million in seed funding. These investments reflect the growing interest and confidence in the potential of AI in healthcare [1].
The broader AI toolkit market is also experiencing robust growth, driven by increasing adoption across various sectors. According to a report by SNS Insider, the Artificial Intelligence Toolkit Market was valued at USD 22.2 billion in 2024 and is projected to reach USD 151.2 billion by 2032, expanding at a CAGR of 23.78% [3]. The market is fueled by the demand for automated workflows, data-driven insights, and intelligent decision-making, with open-source and software segments leading the market.
Moreover, the AI revolution is not confined to startups. Large tech companies like Google, Microsoft, IBM, and NVIDIA are also investing heavily in AI toolkits, indicating a broader trend towards AI integration in healthcare and other industries [3].
The regulatory landscape is gradually becoming more favorable for AI implementation in healthcare. Developers are overcoming barriers, moving closer to real-world implementation. Companies like Avant Technologies, Agenus, Clover Health, Zimmer Biomet, and Monogram Technologies are making progress in this area, further validating the potential of AI in transforming healthcare [1].
In conclusion, the AI revolution in healthcare is well underway, with significant investments and innovations from startups and established companies alike. The market is poised for substantial growth, driven by the potential to save lives and reduce costs. Investors and financial professionals should closely monitor this space for promising opportunities.
References:
[1] https://tracxn.com/d/explore/native-ai-in-healthcare-startups-in-india/__KIHHuaBJBYBU6ve5YGXs1pco5pOrgob_2DWmjE7RKsw/companies
[2] https://www.investing.com/news/company-news/reka-ai-raises-110-million-valuation-tops-1-billion-93CH-4145714
[3] https://www.globenewswire.com/news-release/2025/07/17/3117354/0/en/Artificial-Intelligence-Toolkit-Market-to-Reach-USD-151-2-Billion-by-2032-Driven-by-Enterprise-AI-Adoption-and-Open-Source-Growth-Research-by-SNS-Insider.html
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios